EASCRA THERAPEUTICS Trademark

Trademark Overview


On Thursday, October 14, 2021, a trademark application was filed for EASCRA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the EASCRA THERAPEUTICS trademark a serial number of 97074117. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 9, 2024. This trademark is owned by EASCRA BIOTECH INC. The EASCRA THERAPEUTICS trademark is filed in the Medical Instrument Products category with the following description:

Delivery systems for medicinal therapeutics, namely, Janus Base nanotubes; delivery systems for medicinal therapeutics, namely, mRNA nanotubes; medicinal therapeutics delivery systems for the treatment of diseases, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of cancers and neurological conditions, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of neurological conditions, namely, neurodegenerative diseases, namely, Janus Base nanotubes
eascra therapeutics

General Information


Serial Number97074117
Word MarkEASCRA THERAPEUTICS
Filing DateThursday, October 14, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, May 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2023

Trademark Statements


Translation of Words in MarkThe English translation of "EASCRA" in the mark is "BEAKER".
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesDelivery systems for medicinal therapeutics, namely, Janus Base nanotubes; delivery systems for medicinal therapeutics, namely, mRNA nanotubes; medicinal therapeutics delivery systems for the treatment of diseases, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of cancers and neurological conditions, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of neurological conditions, namely, neurodegenerative diseases, namely, Janus Base nanotubes

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 3, 2021
Primary Code010
First Use Anywhere DateFriday, November 5, 2021
First Use In Commerce DateFriday, November 5, 2021

Trademark Owner History


Party NameEASCRA BIOTECH INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02114

Party NameEASCRA BIOTECH INC
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02114

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressProvidence, RI 02906

Trademark Events


Event DateEvent Description
Monday, October 18, 2021NEW APPLICATION ENTERED
Wednesday, November 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 9, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 20, 2022ASSIGNED TO EXAMINER
Wednesday, July 20, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2022NON-FINAL ACTION E-MAILED
Wednesday, July 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 3, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 7, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 12, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, April 12, 2023USE AMENDMENT FILED
Monday, May 1, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 16, 2023STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 31, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 31, 2023NON-FINAL ACTION E-MAILED
Wednesday, May 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 19, 2024ASSIGNED TO LIE
Friday, January 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 24, 2024SU - FINAL REFUSAL - WRITTEN
Wednesday, January 24, 2024FINAL REFUSAL E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, May 9, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, May 9, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE